A New Zealand man was apprehended Sunday night after jumping into the celebrated Trevi Fountain in central Rome.

Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy ...

Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy ...

Tourists are fined every year for incidents like dipping their toes into the fountain or filling up water bottles from the ...

Trevi Therapeutics has finished enrolling subjects in a trial of investigational Haduvio for treating chronic cough in IPF ...

A New Zealand man has made his last visit to Trevi Fountain after a drunken escapade at the Rome landmark over the weekend.

Three holidaymakers from New Zealand caused a splash when they were spotted wading into the famed fountain by the authorities ...

Trevi Therapeutics (TRVI)has completed enrollment in its Phase 2b CORAL trial of Haduvio for the treatment of chronic cough in patients with ...

In a report released today, Mayank Mamtani from B.Riley Financial reiterated a Buy rating on Trevi Therapeutics (TRVI – Research Report), with ...

“Alcohol was definitely involved,” the spokesperson added.He was fined 500 euros (around $524) and banned from visiting the Baroque landmark for life.The Trevi Fountain, constructed in 1762 as ...

The decision to take a dip in the famous fountain had serious repercussions. The tourist was immediately fined €500, approximately $524, for his actions. Additionally, he was issued a lifetime ban ...